Want to see JP:6092 full AI Analyst Report?
Top Page
EnBio Holdings, Inc.
(6092)
Select Model
Select Model
Rating:58Neutral
Price Target:
¥808.00
▲(35.12% Upside)
Action:Reiterated
Date:08/18/26
The score is primarily constrained by weakening profitability, elevated leverage, and volatile/free cash flow despite strong revenue growth. Technicals are supportive but very overbought, increasing short-term risk. Valuation is relatively reasonable (P/E ~13.18, ~1% yield), providing some offset.
Positive Factors
Strong Revenue Growth
Sustained double-digit revenue growth indicates that EnBio is expanding demand and maintaining commercial traction. If this momentum persists, a larger operating base could support improved earnings power and provide resources for continued investment over the next several quarters.
Negative Factors
Material Profitability Decline
Falling net margins show that stronger sales are not translating proportionally into earnings. The decline reduces the company’s ability to self-fund expansion, leaves less protection against operating pressure, and makes the durability of future profit growth dependent on restoring cost or pricing discipline.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth
Sustained double-digit revenue growth indicates that EnBio is expanding demand and maintaining commercial traction. If this momentum persists, a larger operating base could support improved earnings power and provide resources for continued investment over the next several quarters.
Read all positive factors
EnBio Holdings, Inc. (6092) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥6.37B
Dividend Yield1.16%
Average Volume (3M)21.07K
Price to Earnings (P/E)11.4
Beta (1Y)0.37
Revenue Growth28.93%
EPS Growth401.18%
CountryJP
Employees113
SectorIndustrials
Sector Strength72
IndustryEnvironmental Services
Share Statistics
EPS (TTM)32.70
Shares Outstanding8,175,200
10 Day Avg. Volume20,920
30 Day Avg. Volume21,070
Financial Highlights & Ratios
PEG Ratio-0.56
Price to Book (P/B)0.67
Price to Sales (P/S)0.49
P/FCF Ratio51.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EnBio Holdings, Inc. Business Overview & Revenue Model
Company Description
EnBio Holdings, Inc. engages in the provision of soil pollution countermeasure services. It operates through the following segments: Soil Pollution Countermeasures, Brownfield Utilization, and Natural Energy. The Soil Pollution Countermeasures seg...
How the Company Makes Money
null...
EnBio Holdings, Inc. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
56
Neutral
Cash Flow
45
Neutral
| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 12.63B | 10.67B | 9.58B | 8.12B | 8.99B |
| Gross Profit | 3.69B | 2.65B | 2.48B | 2.76B | 2.43B |
| EBITDA | 2.16B | 1.35B | 1.25B | 1.76B | 1.59B |
| Net Income | 265.00M | 452.69M | 708.76M | 812.06M | 654.06M |
Balance Sheet | |||||
| Total Assets | 22.85B | 21.20B | 19.31B | 17.35B | 16.37B |
| Cash, Cash Equivalents and Short-Term Investments | 4.04B | 3.29B | 3.60B | 2.83B | 2.37B |
| Total Debt | 10.65B | 10.10B | 8.62B | 8.90B | 8.58B |
| Total Liabilities | 13.52B | 11.96B | 10.72B | 10.49B | 10.40B |
| Stockholders Equity | 9.25B | 9.14B | 8.49B | 6.79B | 5.89B |
Cash Flow | |||||
| Free Cash Flow | 119.00M | -1.44B | 584.36M | 826.37M | 1.25B |
| Operating Cash Flow | 1.17B | 21.92M | 1.66B | 1.99B | 2.41B |
| Investing Cash Flow | -891.00M | -1.60B | -1.58B | -1.77B | -1.48B |
| Financing Cash Flow | 460.00M | 1.27B | 638.92M | 240.73M | -534.92M |
EnBio Holdings, Inc. Technical Analysis
Negative
598.00
Price Trends
796.46
Negative
773.52
Positive
731.99
Positive
Market Momentum
-8.68
Positive
37.81
Neutral
24.88
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6092, the sentiment is Negative. The current price of 598 is below the 20-day moving average (MA) of 810.70, below the 50-day MA of 796.46, and below the 200-day MA of 731.99, indicating a neutral trend. The MACD of -8.68 indicates Positive momentum. The RSI at 37.81 is Neutral, neither overbought nor oversold. The STOCH value of 24.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6092.
EnBio Holdings, Inc. Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | ¥14.31B | 8.24 | ― | 4.06% | -2.31% | -25.42% | |
64 Neutral | ¥8.89B | 6.60 | ― | 3.10% | 2.44% | 19.66% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥20.24B | 10.33 | ― | 3.66% | 5.58% | -3.65% | |
63 Neutral | ¥6.44B | 46.54 | ― | ― | 24.06% | -66.01% | |
62 Neutral | ¥11.27B | 10.70 | ― | 3.27% | 25.06% | 9.09% | |
58 Neutral | ¥6.37B | 11.38 | ― | 1.16% | 28.93% | 401.18% |
* Industrials Sector Average
JP:6092
EnBio Holdings, Inc.
777.00
205.61
35.98%
JP:4809
Paraca Inc.
1,969.00
85.79
4.56%
JP:7049
SHIKIGAKU Co., Ltd.
761.00
-65.00
-7.87%
JP:7987
Nakabayashi Co., Ltd.
542.00
-19.39
-3.45%
JP:9325
PHYZ Holdings, Inc.
1,041.00
-114.06
-9.88%
JP:9791
Biken Techno Corporation
1,162.00
-27.88
-2.34%
EnBio Holdings, Inc. Corporate Events
EnBio Holdings Delivers Profit Rebound and Affirms Full-Year Outlook
Aug 14, 2026
EnBio Holdings reported a strong rebound in earnings for the three months ended June 30, 2026, with net sales rising 16.5% year on year to ¥2,841 million and operating profit surging 246.3% to ¥407 million. Profit attributable to owners ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.